Belzutifan is a kind of HIF-2α pseudo-inhibitor. It’s used to treat VHL-related renal cell carcinoma. It works by cutting down tumor hypoxia signals.
You can get this drug in 40 mg film-coated tablet form. Doctors usually suggest a dose of 120 mg a day. Each bottle has 90 of these tablets.
Reviews
There are no reviews yet.